Literature DB >> 21218075

Antidiabetic and Free Radicals Scavenging Potential of Euphorbia hirta Flower Extract.

S Kumar1, R Malhotra, D Kumar.   

Abstract

The present study was carried out to evaluate antidiabetic and in vitro free radicals scavenging effects of flower extract of Euphorbia hirta. The ethanolic and petroleum ether extracts (250 and 500 mg/kg) were orally tested for 21 days in alloxan induced diabetic mice and blood glucose level was measured with glucometer. Administration of extract resulted in significant reduction in serum cholesterol, triglycerides, creatinine, urea, alkaline phosphatase levels but high density lipoprotein levels and total proteins were found to be increased after treatments. Free radicals scavenging effect of ethanolic extract was also evaluated by various antioxidant assays, including 1, 1-diphenyl-2-picryl hydrazyl free radical scavenging activity, superoxide anion radical scavenging, nitric oxide scavenging, and reducing power assay. It was compared with standard antioxidants compounds such as butylated hydroxyl anisole and ascorbic acid. All the extracts showed antioxidant activity in all the tested methods.

Entities:  

Keywords:  Alloxan; Euphorbia hirta; antidiabetic; free radicals; mice; nitric oxide; superoxide

Year:  2010        PMID: 21218075      PMCID: PMC3013561          DOI: 10.4103/0250-474X.73921

Source DB:  PubMed          Journal:  Indian J Pharm Sci        ISSN: 0250-474X            Impact factor:   0.975


Diabetes mellitus is a metabolic disease characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. It is well documented that chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and eventually the failure of organs, especially the eyes, kidneys, nerves, heart, and blood vessels[1]. Synthetic antidiabetic agents can produce serious side effects and they are not suitable for use during pregnancy[2]. In view of the adverse effects associated with the synthetic drugs and as plants are safer, cheaper and much effective, conventional antidiabetic plants can be explored[3]. Furthermore, after the recommendation made by WHO on diabetes mellitus, investigations on hypoglycaemic agents from medicinal plants have become more important[4]. Euphorbia hirta (Euphorbiaceae), commonly known as Dudhi is an annual hairy plant. It is abundant in waste places along the roadsides and open grasslands. It is native to India and Australia[5]. The E. hirta have been reported to contain alkaloids, saponins, flavonoids, tannins phenolic acids and amino acids[6]. Traditionally, it is used in treatment of gastrointestinal disorders, bronchial and respiratory diseases, kidney stones, diabetes and in conjunctivitis. It also exhibits antipyretic, analgesic, antibacterial, anxiolytic, anthelmintic, antifertility, antispasmodic, antifungal, and antiinflammatory activities[7-9]. Our literature survey revealed that there is no experimental evidence of antidiabetic effect of the plant. Therefore, the present study has been planned to investigate how the ethanolic and petroleum ether flower extracts of E. hirta influences lipid parameters in alloxan induced diabetic mice. All standard kits were purchased from Erba diagnostics Mannheim Gambh, Germany. Blood glucose level was measured using Elegance glucose meter (CT-X10) of Convergent Technologies, Germany. Alloxan was purchased from Loba Chemie pvt. Ltd. Mumbai, India. All other chemicals used in the study were of analytical grade. Flowers of E. hirta were collected in the month of September-October, 2008 from campus of Kurukshetra University, Kurukshetra, India and were identified at the Department of Botany, Kurukshetra University, Kurukshetra, India. A voucher specimen of the plant is preserved in the herbarium of the Faculty of Pharmaceutical Sciences, Kurukshetra University (No. IPS/KUK/E-1/2009). The flowers were washed with water and dried in shade. The dried flowers were powdered by using dry grinder and passed through sieve. This powder was packed into soxhlet apparatus and extracted successively with petroleum ether (60-80°) and ethanol (yield 26.83 and 24.74% respectively). All the extracts were dried at 45°in rotary evaporator to produce a semisolid mass and stored in airtight containers in refrigerator below 10°. Albino mice of either sex, weighing about 30-35 g were used in the experiment. Animals were maintained under standard environmental conditions i.e. ambient temperature of 22±2 °and at 45–55% relative humidity for 12 h, each of dark and light cycle and fed with a standard pellet mice diet obtained from Ashirwad Industries, Chandigarh, India and water was supplied ad libitum. All the studies were conducted in accordance with the Animal Ethical Committee of the University. Mice were made diabetic by a single intraperitoneal injection of freshly prepared alloxan (150 mg/kg i.p.) in sterile saline. Twelve days after alloxan injection, animals shown blood glucose level >140 mg/dl were considered as diabetic and used for the study. In the experiment, mice were divided into seven groups of six mice each. Group I (Normal healthy control) received only vehicle (Tween 80, 5% v/v). Group II (Diabetic control) received vehicle only. In group III and IV diabetic mice received petroleum ether flower extract 250 and 500 mg/kg respectively). In group V and VI diabetic mice received ethanol flower extract (250 and 500 mg/kg respectively). Group VII was treated with glibenclamide (10 mg/kg). The mice were given extracts for 21 days once daily by oral route using an intragastric tube. Blood glucose levels were measured using blood glucose test strips with elegance glucometer (Frankenberg, Germany) at random on initial, seventh, fourteenth, and twenty first day by taking blood samples from tail vein puncture under light ether anesthesia[10]. After blood glucose estimation on day 21, whole blood was collected by cardiac puncture under mild ether anesthesia from mice. Serum cholesterol, triglycerides, HDL, VLDL and LDL were also evaluated in normal and alloxan induced diabetic mice. The total cholesterol is measured using diagnostic kits, Boehringer Mannheim, Germany. Total cholesterol and triglycerides were determined by the method of Rifai et al.[11] HDL was measured by the method of Burstein et al.[12] The VLDL cholesterol was calculated using the formula (TG/5) mg/dl. The serum LDL cholesterol was estimated by the method of Friedwald et al.[13] Serum creatinine, urea, alkaline phosphatase and total proteins levels were also evaluated in normal and alloxan induces diabetic mice. Serum urea and creatinine were assayed by the method of Tomas,[1415]. Total proteins[16] and alkaline phosphatase were assayed by the method of Wilkinson et al.[17] Antioxidant activity of E. hirta (ethanolic flower extract) was evaluated by following methods: DPPH free radical scavenging activity[18], superoxide radical scavenging assay[1920], nitric oxide scavenging activity[21], and reducing power assay[22]. All the values of body weight, blood glucose and biochemical estimations were expressed as mean±standard error of mean (SEM) and comparison between the groups was made by student t- test. A valve of p < 0.001 was considered significant. Antidiabetic effect of the extracts on the blood glucose levels of diabetic mice is shown in Table 1. Daily treatment of flower extracts for three weeks led to a dose dependent fall in blood glucose levels. Maximum effect seems to reach after 15 days of treatment and remains constant in third week. Administration of alloxan led to elevation of blood glucose levels, which was maintained over a period of three weeks. As shown both extracts induced significant (p<0.001) antidiabetic effects in dose-dependent fashion when compared to the control group.
TABLE 1

LONG TERM EFFECTS OF E. HIRTA EXTRACTS ON THE BLOOD GLUCOSE LEVELS IN NORMAL AND DIABETIC MICE

GroupsBlood glucose level (mg/dl)
Initial dayDay 7Day 14Day 21
Normal control72.25±0.8973.5±1.073.75±0.8675.5±1.58
Diabetic control185±2.88186.2±1.7189.25±1.25192.5±1.73
Petroleum ether extract (250 mg/kg)193.75±5.6*175±5.8162.7±3.1**118.75±4.4**
Petroleum ether extract (500 mg/kg)175.5±1.4*152.5±1.4140.2±2.9**110.5±1.7**
Alcoholic extract (250 mg/kg)172.7±0.8121±1.2**105.5±1.8**86.2±0.5**
Alcoholic extract (500 mg/kg)182.2±5.7133.5±3.7**124.5±2.7**88.2±1.2**
Glibenclamide (10 mg/kg)194.75±2.84156.5±5.95**116.5±5.24**83.75±4.5*

Each value is the mean ±SEM. of 6 mice in each group

p<0.05

p<0.001

LONG TERM EFFECTS OF E. HIRTA EXTRACTS ON THE BLOOD GLUCOSE LEVELS IN NORMAL AND DIABETIC MICE Each value is the mean ±SEM. of 6 mice in each group p<0.05 p<0.001 After 21 days, serum lipid profile was measured and it was found that serum cholesterol and triglyceride levels were decreased (p<0.01) by both the extracts and glibenclamide as compared to diabetic control but HDL level was found to be increased after treatments (Table 2). Other biochemical parameters such as serum creatinine, urea and alkaline phosphatase levels were found to be decreased whereas total proteins were found to be increased after treatments (Table 3).
TABLE 2

EFFECT OF CHRONIC EXPOSURE TO E. HIRTA EXTRACTS ON LIPID PROFILE

GroupsCholesterolTriglyceridesHDL CholesterolVLDL CholesterolLDL Cholesterol
Normal control159.58±5.882.42±5.135±1.916.48±1.597.52±2.1
Diabetic control257.83±14.6250.62±12.730±1.250.12±1.4177.71±7.4*
Pet. ether extract (250 mg/kg)182.9±11.8199±5.935.6±2.139.8±2.5107.5±1.5
Pet. ether extract (500 mg/kg)178.7±4.7*188 ±4.739.2±1.4*37.6±2.1101.8±3.7*
Ethanol extract (250 mg/kg)150.4±6.4134±2.149.6±1.826.8±0.1*84.3±3.2*
Ethanol extract (500 mg/kg)146.3±5.9131±1.950.2±2.126.2±2.7*80.8±1.8
Glibenclamide (10 mg/kg)120.16±5.7*102±6.5*64.52±1.920.4±2.8*35.24±5.4*

Values are expressed as mg/dl, Each value is the mean±SEM of 6 mice in each group

p<0.01

TABLE 3

EFFECT OF CHRONIC EXPOSURE TO E. HIRTA EXTRACTS ON OTHER BIOCHEMICAL PARAMETERS

GroupsCreatinine (mg/dl)Urea (mg/dl)Alkaline phosphataseTotal proteins (g/dl)
Normal control0.61± 0.124.24 ±1.8119.46±3.77.1±2.3
Diabetic control1.53±0.172.00±2.4351.40±6.24.3±4.62
Pet. ether extract (250 mg/kg)0.79±0.650.46±3.9270.2±5.95±0.3*
Pet. ether extract (500 mg/kg)0.84±0.146±1.0*240.6±6.45.3±2.3
Ethanolic extract (250 mg/kg)0.59±0.542.2±1.4151.2±4.94.8 ±1.3
Ethanolic extract (500 mg/kg)0.64±0.132.7±1.7*147.9 ±9.75.9±1.9*
Glibenclamide (10 mg/kg)0.42±0.1*30.00±3.2*110.27±3.9*8.4±1.4*

Each value is the mean±SEM of 6 mice in each group

p<0.01

EFFECT OF CHRONIC EXPOSURE TO E. HIRTA EXTRACTS ON LIPID PROFILE Values are expressed as mg/dl, Each value is the mean±SEM of 6 mice in each group p<0.01 EFFECT OF CHRONIC EXPOSURE TO E. HIRTA EXTRACTS ON OTHER BIOCHEMICAL PARAMETERS Each value is the mean±SEM of 6 mice in each group p<0.01 Normal healthy control was found to be stable in their body weight but diabetic mice showed reduction in the body weight. In this study, the decrease of body weights was diminished by the extract treatments after 14 days of treatment (Table 4).
TABLE 4

EFFECT OF E. HIRTA EXTRACTS ON THE BODY WEIGHT IN NORMAL AND DIABETIC MICE

GroupsChange in body weight
Initial dayDay 7Day 14Day 21
Normal control27.3±1.927.96±1.531.11±3.828.59±1.1
Diabetic control30.3±1.226.53±3.228.95±3.227.2±2.4
Petroleum ether extract (250 mg/kg)25.6±1.824±1.721.7±2.025.6±3.2*
Petroleum ether extract (500 mg/kg)26.7±2.025.2±1.923.4±1.826.7±2.0*
Alcoholic extract (250 mg/kg)27.3±2.024.6±1.722.5±1.727.3±2.4
Alcoholic extract (500 mg/kg)28.8±1.726.7±1.524.5±1.528.8±2.1*
Glibenclamide (10 mg/kg)26.2±1.827.7±2.0*29.89±2.230.46±1.9*

Each value is the mean±SEM of 6 mice in each group

p<0.01

EFFECT OF E. HIRTA EXTRACTS ON THE BODY WEIGHT IN NORMAL AND DIABETIC MICE Each value is the mean±SEM of 6 mice in each group p<0.01 Both extracts of flower of E. hirta have significant antioxidant activity compared to other well characterized, standard antioxidant systems. Free radical scavenging potential was assessed against DPPH. The scavenging effect of alcoholic extract on the DPPH radical was 50.2%, at a concentration of 250 μg/ml. The reductive capabilities of extract were compared with ascorbic acid and BHA. The extract showed dose dependent reducing power. In the nitric oxide scavenging study, crude extract was checked for its inhibitory effect on nitric oxide production. The percentage inhibition of superoxide generation by 250 μg/ml concentration of extract was measured as 66.12%. The antioxidant activity of extract and standard compounds were compared by using specific in vitro methods (Table 5).
TABLE 5

ANTIOXIDANT PROFILE OF E. HIRTA FLOWER EXTRACT

SampleSample conc. (μg/ml)DPPH radical scavenging activity (% inhibition)Superoxide anion scavenging activity (% inhibition)Percentage scavenging of nitric oxideReducing power activitya (absorbance)
Alcoholic extract25050.2±1.7*66.12±1.5*34.6±2.1*0.540
Ascorbic acid25095.44±1.4*69.16±1.639.86±2.10.292
BHA25088.05±1.0*67.74±3.1*30.89 ±2.7*0.248

Increased absorbance indicates increased reducing power All values represent Mean±SEM

p<0.01

ANTIOXIDANT PROFILE OF E. HIRTA FLOWER EXTRACT Increased absorbance indicates increased reducing power All values represent Mean±SEM p<0.01 Traditional plant medicines are used throughout the world for treatment of various diseases and disorders. Worldwide, over 1200 species of plants have been recorded as traditional medicine for diabetes. Herbal drugs are prescribed widely because of their effectiveness, less side effects and relatively low cost[23]. Therefore, investigation on such agents from traditional medicinal plants has become more important. Euphorbia prostrata, the plant of same genus has been reported to have hypoglycemic effect[24]. Keeping in view of this and traditional uses, the ethanolic and petroleum ether extracts of E. hirta flowers were investigated for its antidiabetic activity and long-term effects on the body weights. Significant reduction of blood glucose levels is observed in alloxan induced diabetic mice treated with E. hirta flower exract (p<0.001). The repeated administration of Euphorbia hirta extract for a period of 21 days resulted in a significant decrease in lipid parameter levels of various tissues when compared to the diabetic control. It is not known whether E. hirta has a direct effect on lipids or the present hypolipidemia is achieved due to controlled hyperglycemia. Different studies have shown that Diabetes mellitus is associated with the increased formation of free radicals and decrease in antioxidant potential. In both insulin dependent and insulin independent diabetes, there is increased oxidative stress[25]. So, free radical scavenging and antioxidant effect may be responsible for its antidiabetic effect. It is possible that extract exert its effect by causing hypoglycemia. The exact mechanism of antidiabetic activity is still unclear but it may be due antioxidant and free radical scavenging effect of the plant and presence of flavanoids, tannins and other phenolic compounds in the extracts. Thus, our study shows that oral administration of E. hirta flower extracts in alloxan diabetic mice showed antidiabetic effects. The extracts also exhibit in vitro antioxidative effect. Further phytochemical and pharmacological investigations are needed to isolate and identify the active constituents responsible for the activity.
  13 in total

1.  The hypoglycaemic activity of the aqueous extract of Stachytarpheta angustifolia (Verbanaceae) in normoglycaemic and alloxan-induced diabetic rats.

Authors:  A B Isah; Y K E Ibrahim; E M Abdulrahman; M A Ibrahim
Journal:  Pak J Biol Sci       Date:  2007-01-01

2.  Effect of aqueous Euphorbia hirta leaf extract on gastrointestinal motility.

Authors:  S K Hore; V Ahuja; G Mehta; Pardeep Kumar; S K Pandey; A H Ahmad
Journal:  Fitoterapia       Date:  2005-10-27       Impact factor: 2.882

3.  The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen.

Authors:  M Nishikimi; N Appaji; K Yagi
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

4.  Evaluation of a new system for the kinetic measurement of serum alkaline phosphatase.

Authors:  J H Wilkinson; J H Boutwell; S Winsten
Journal:  Clin Chem       Date:  1969-06       Impact factor: 8.327

5.  Free radical scavenging activity of curcuminoids.

Authors:  N Sreejayan; M N Rao
Journal:  Arzneimittelforschung       Date:  1996-02

Review 6.  Leads from Indian medicinal plants with hypoglycemic potentials.

Authors:  Pulok K Mukherjee; Kuntal Maiti; Kakali Mukherjee; Peter J Houghton
Journal:  J Ethnopharmacol       Date:  2006-04-03       Impact factor: 4.360

Review 7.  Medicinal plants of India with anti-diabetic potential.

Authors:  J K Grover; S Yadav; V Vats
Journal:  J Ethnopharmacol       Date:  2002-06       Impact factor: 4.360

8.  Protective effects of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin-induced diabetes.

Authors:  Mustafa Naziroğlu; Peter J Butterworth
Journal:  Can J Appl Physiol       Date:  2005-04

9.  Determination of in vitro antioxidant and radical scavenging activities of propofol.

Authors:  Ilhami Gülçin; Haci Ahmet Alici; Mehmet Cesur
Journal:  Chem Pharm Bull (Tokyo)       Date:  2005-03       Impact factor: 1.645

10.  Studies on the antioxidant activities of Desmodium gangeticum.

Authors:  Raghavan Govindarajan; Subha Rastogi; Madhavan Vijayakumar; Annie Shirwaikar; Ajay Kumar Singh Rawat; Shanta Mehrotra; Palpu Pushpangadan
Journal:  Biol Pharm Bull       Date:  2003-10       Impact factor: 2.233

View more
  9 in total

1.  Histological changes and antidiabetic activities of Icacina trichantha tuber extract in beta-cells of alloxan induced diabetic rats.

Authors:  Onakpa Michael Monday; Asuzu Isaac Uzoma
Journal:  Asian Pac J Trop Biomed       Date:  2013-08

2.  Antidiabetic and hypolipidemic activities of Kigelia pinnata flowers extract in streptozotocin induced diabetic rats.

Authors:  S Kumar; V Kumar; O M Prakash
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

Review 3.  Hydroxyl radical and its scavengers in health and disease.

Authors:  Boguslaw Lipinski
Journal:  Oxid Med Cell Longev       Date:  2011-07-17       Impact factor: 6.543

4.  Antidiabetic activities of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin-induced diabetic rats.

Authors:  Alemayehu Toma; Eyasu Makonnen; Yelamtsehay Mekonnen; Asfaw Debella; Sirichai Adisakwattana
Journal:  BMC Complement Altern Med       Date:  2015-07-18       Impact factor: 3.659

5.  HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia.

Authors:  Gunasekaran Baskaran; Shamala Salvamani; Siti Aqlima Ahmad; Noor Azmi Shaharuddin; Parveen Devi Pattiram; Mohd Yunus Shukor
Journal:  Drug Des Devel Ther       Date:  2015-01-14       Impact factor: 4.162

6.  Serum Biochemical, Histopathology and SEM Analyses of the Effects of the Indian Traditional Herb Wattakaka Volubilis Leaf Extract on Wistar Male Rats.

Authors:  Velmani Gopal; Vivekananda Mandal; Sumpam Tangjang; Subhash C Mandal
Journal:  J Pharmacopuncture       Date:  2014-03

7.  Novel Weed-Extracted Silver Nanoparticles and Their Antibacterial Appraisal against a Rare Bacterium from River and Sewage Treatment Plan.

Authors:  Achmad Syafiuddin; Tony Hadibarata; Ahmad Beng Hong Kueh; Mohd Razman Salim
Journal:  Nanomaterials (Basel)       Date:  2017-12-26       Impact factor: 5.076

8.  Wound healing effect of Euphorbia hirta linn. (Euphorbiaceae) in alloxan induced diabetic rats.

Authors:  Riazul Haque Tuhin; Mst Marium Begum; Md Sohanur Rahman; Rubaba Karim; Taslima Begum; Siraj Uddin Ahmed; Ronia Mostofa; Amir Hossain; Mohamed Abdel-Daim; Rayhana Begum
Journal:  BMC Complement Altern Med       Date:  2017-08-24       Impact factor: 3.659

Review 9.  Contributions from Mexican Flora for the Treatment of Diabetes Mellitus: Molecules of Psacalium decompositum (A. Gray) H. Rob & Brettell.

Authors:  Manuel Jiménez-Estrada; Maira Huerta-Reyes; Rosario Tavera-Hernández; J Javier Alvarado-Sansininea; Ana Berenice Alvarez
Journal:  Molecules       Date:  2021-05-13       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.